Old Web
English
Sign In
Acemap
>
Paper
>
P21.13 Durvalumab in Locally-Advanced NSCLC in LATAM: Real World Data from Patients Included in the Early Access Program
P21.13 Durvalumab in Locally-Advanced NSCLC in LATAM: Real World Data from Patients Included in the Early Access Program
2021
F. Tsou
M Angel
F Reinhold
C. Gabay
M. Bonet
M.V. Bluthgen
J. Minatta
B Bustos
C. Novas
M. Rizzo
R Kowalyszyn
J. Cundom
E. Richardet
G. Ferreira
D. Gomez Bradley
G Roa
M. Tatangelo
C Caglevic
A. Pini
M. Paskevicius
M. Flores
C. Pupareli
C. Martin
Keywords:
Durvalumab
Medical physics
locally advanced
real world data
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]